Comparison of Plasma Exosome Proteomes Between Obese and Non-Obese Patients with Type 2 Diabetes Mellitus

References

• Blum M, Chang HY, Chuguransky S, et al. The InterPro protein families and domains database: 20 years on. Nucleic Acids Res. 2021;49(D1):D344–D354. doi:10.1093/nar/gkaa977
   PubMed Web of Science ®Google Scholar
• Panuganti KK, Nguyen M, Kshirsagar RK. Obesity. Treasure Island (FL): StatPearls; 2022.
   Google Scholar
• Fried M, Yumuk V, Oppert JM, et al. Interdisciplinary European Guidelines on metabolic and bariatric surgery. Obes Facts. 2013;6(5):449–468. doi:10.1159/000355480
   PubMed Web of Science ®Google Scholar
• AlShahrani MS. Prevalence of obesity and overweight among type 2 diabetic patients in Bisha, Saudi Arabia. J Family Med Prim Care. 2021;10(1):143–148. doi:10.4103/jfmpc.jfmpc_1349_20
   PubMedGoogle Scholar
• Dyson PA. The therapeutics of lifestyle management on obesity. Diabetes Obes Metab. 2010;12(11):941–946.
   PubMed Web of Science ®Google Scholar
• Wondmkun YT. Obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications. Diabetes Metab Syndr Obes. 2020;13:3611–3616.
   PubMed Web of Science ®Google Scholar
• Romero A, Eckel J. Organ crosstalk and the modulation of insulin signaling. Cells. 2021;10(8):2082.
   PubMed Web of Science ®Google Scholar
• Lopez-Villar E, Martos-Moreno GA, Chowen JA, Okada S, Kopchick JJ, Argente J. A proteomic approach to obesity and type 2 diabetes. J Cell Mol Med. 2015;19(7):1455–1470.
   PubMed Web of Science ®Google Scholar
• Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8(7):727.
   PubMed Web of Science ®Google Scholar
• Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789–804. doi:10.7150/thno.18133
   PubMed Web of Science ®Google Scholar
• Andreu Z, Yanez-Mo M. Tetraspanins in extracellular vesicle formation and function. Front Immunol. 2014;5:442. doi:10.3389/fimmu.2014.00442
   PubMed Web of Science ®Google Scholar
• Song M, Han L, Chen FF, et al. Adipocyte-derived exosomes carrying sonic hedgehog mediate M1 macrophage polarization-induced insulin resistance via ptch and PI3K pathways. Cell Physiol Biochem. 2018;48(4):1416–1432. doi:10.1159/000492252
   PubMedGoogle Scholar
• Wu J, Dong T, Chen T, et al. Hepatic exosome-derived miR-130a-3p attenuates glucose intolerance via suppressing PHLPP2 gene in adipocyte. Metabolism. 2020;103:154006. doi:10.1016/j.metabol.2019.154006
   PubMed Web of Science ®Google Scholar
• Aswad H, Forterre A, Wiklander OP, et al. Exosomes participate in the alteration of muscle homeostasis during lipid-induced insulin resistance in mice. Diabetologia. 2014;57(10):2155–2164. doi:10.1007/s00125-014-3337-2
   PubMed Web of Science ®Google Scholar
• Noren Hooten N, Evans MK. Extracellular vesicles as signaling mediators in type 2 diabetes mellitus. Am J Physiol Cell Physiol. 2020;318(6):C1189–C1199. doi:10.1152/ajpcell.00536.2019
   PubMed Web of Science ®Google Scholar
• Afrisham R, Sadegh-Nejadi S, Meshkani R, Emamgholipour S, Paknejad M. Effect of circulating exosomes derived from normal-weight and obese women on gluconeogenesis, glycogenesis, lipogenesis and secretion of FGF21 and fetuin A in HepG2 cells. Diabetol Metab Syndr. 2020;12:32. doi:10.1186/s13098-020-00540-4
   PubMed Web of Science ®Google Scholar
• Lee JE, Moon PG, Lee IK, Baek MC. Proteomic analysis of extracellular vesicles released by adipocytes of Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Protein J. 2015;34(3):220–235. doi:10.1007/s10930-015-9616-z
   PubMed Web of Science ®Google Scholar
• Ramachandrarao SP, Hamlin AA, Awdishu L, et al. Proteomic analyses of urine exosomes reveal new biomarkers of diabetes in pregnancy. Madridge J Diabetes. 2016;1(1):11–22. doi:10.18689/mjd-1000103
   PubMedGoogle Scholar
• Wang J, Zhang Y, Yang Y, et al. The prevalence and independent influencing factors of obesity and underweight in patients with schizophrenia: a multicentre cross-sectional study. Eat Weight Disord. 2021;26(5):1365–1374. doi:10.1007/s40519-020-00920-9
   PubMed Web of Science ®Google Scholar
• Jung MK, Mun JY. Sample preparation and imaging of exosomes by transmission electron microscopy. J Vis Exp. 2018;131. doi:10.3791/56482-v
   Google Scholar
• Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6(5):359–362. doi:10.1038/nmeth.1322
   PubMed Web of Science ®Google Scholar
• Gotz S, Garcia-Gomez JM, Terol J, et al. High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res. 2008;36(10):3420–3435. doi:10.1093/nar/gkn176
   PubMed Web of Science ®Google Scholar
• Horton P, Park KJ, Obayashi T, et al. WoLF PSORT: protein localization predictor. Nucleic Acids Res. 2007;35:W585–W587. doi:10.1093/nar/gkm259
   PubMed Web of Science ®Google Scholar
• Quevillon E, Silventoinen V, Pillai S, et al. InterProScan: protein domains identifier. Nucleic Acids Res. 2005;33:W116–W120. doi:10.1093/nar/gki442
   PubMed Web of Science ®Google Scholar
• Hu H, Miao YR, Jia LH, Yu QY, Zhang Q, Guo AY. AnimalTFDB 3.0: a comprehensive resource for annotation and prediction of animal transcription factors. Nucleic Acids Res. 2019;47(D1):D33–D38. doi:10.1093/nar/gky822
   PubMed Web of Science ®Google Scholar
• Jin J, Tian F, Yang DC, et al. PlantTFDB 4.0: toward a central hub for transcription factors and regulatory interactions in plants. Nucleic Acids Res. 2017;45(D1):D1040–D1045. doi:10.1093/nar/gkw982
   PubMed Web of Science ®Google Scholar
• Gupta A, Gupta AK, Singh TP. Occurrence of complications in newly diagnosed type 2 diabetes patients: a hospital based study. J Indian Med Assoc. 2013;111(4):245–247.
   PubMedGoogle Scholar
• Shim K, Begum R, Yang C, Wang H. Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus. World J Diabetes. 2020;11(1):1–12. doi:10.4239/wjd.v11.i1.1
   PubMed Web of Science ®Google Scholar
• Ghosh P, Sahoo R, Vaidya A, Chorev M, Halperin JA. Role of complement and complement regulatory proteins in the complications of diabetes. Endocr Rev. 2015;36(3):272–288. doi:10.1210/er.2014-1099
   PubMed Web of Science ®Google Scholar
• Wlazlo N, van Greevenbroek MM, Ferreira I, et al. Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: the CODAM study. Metabolism. 2012;61(12):1787–1796. doi:10.1016/j.metabol.2012.05.015
   PubMed Web of Science ®Google Scholar
• Sharp TH, Koster AJ, Gros P. Heterogeneous MAC initiator and pore structures in a lipid bilayer by phase-plate cryo-electron tomography. Cell Rep. 2016;15(1):1–8. doi:10.1016/j.celrep.2016.03.002
   PubMed Web of Science ®Google Scholar
• Hannan JP, Laskowski J, Thurman JM, Hageman GS, Holers VM. Mapping the complement factor H-related protein 1 (CFHR1): c3b/C3dInteractions. PLoS One. 2016;11(11):e0166200. doi:10.1371/journal.pone.0166200
   PubMed Web of Science ®Google Scholar
• Heinen S, Hartmann A, Lauer N, et al. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood. 2009;114(12):2439–2447. doi:10.1182/blood-2009-02-205641
   PubMed Web of Science ®Google Scholar
• Gan W, Wu J, Lu L, et al. Associations of CFH polymorphisms and CFHR1-CFHR3 deletion with blood pressure and hypertension in Chinese population. PLoS One. 2012;7(7):e42010. doi:10.1371/journal.pone.0042010
   PubMed Web of Science ®Google Scholar
• Kota SK, Meher LK, Kota SK, Jammula S, Krishna SV, Modi KD. Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia. Indian J Endocrinol Metab. 2013;17(3):402–412. doi:10.4103/2230-8210.111618
   PubMedGoogle Scholar
• Ferretti G, Bacchetti T, Moroni C, et al. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab. 2005;90(3):1728–1733. doi:10.1210/jc.2004-0486
   PubMed Web of Science ®Google Scholar
• Koncsos P, Seres I, Harangi M, et al. Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels. Pediatr Res. 2010;67(3):309–313. doi:10.1203/PDR.0b013e3181c9fb66
   PubMed Web of Science ®Google Scholar
• Ferretti G, Bacchetti T, Busni D, Rabini RA, Curatola G. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients. J Clin Endocrinol Metab. 2004;89(6):2957–2962. doi:10.1210/jc.2003-031897
   PubMed Web of Science ®Google Scholar
• Karabina SA, Lehner AN, Frank E, Parthasarathy S, Santanam N. Oxidative inactivation of paraoxonase--implications in diabetes mellitus and atherosclerosis. Biochim Biophys Acta. 2005;1725(2):213–221.
   PubMed Web of Science ®Google Scholar
• Flekac M, Skrha J, Zidkova K, Lacinova Z, Hilgertova J. Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus. Physiol Res. 2008;57(5):717–726.
   PubMed Web of Science ®Google Scholar
• Mehta NU, Reddy ST. Role of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseases. Curr Opin Lipidol. 2015;26(5):384–387. doi:10.1097/MOL.0000000000000208
   PubMed Web of Science ®Google Scholar
• Lei LM, Lin X, Xu F, et al. Exosomes and obesity-related insulin resistance. Front Cell Dev Biol. 2021;9:651996. doi:10.3389/fcell.2021.651996
   PubMed Web of Science ®Google Scholar
• Shashkin P, Koshkin A, Langley D, Ren JM, Westerblad H, Katz A. Effects of CGS 9343B (a putative calmodulin antagonist) on isolated skeletal muscle. Dissociation of signaling pathways for insulin-mediated activation of glycogen synthase and hexose transport. J Biol Chem. 1995;270(43):25613–25618. doi:10.1074/jbc.270.43.25613
   PubMed Web of Science ®Google Scholar
• Brozinick JT, Reynolds TH, Dean D, Cartee G, Cushman SW. 1-[N, O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosyl]-4- phenylpiperazine (KN-62), an inhibitor of calcium-dependent camodulin protein kinase II, inhibits both insulin- and hypoxia-stimulated glucose transport in skeletal muscle. Biochem J. 1999;339(Pt 3)):533–540. doi:10.1042/bj3390533
   PubMedGoogle Scholar
• Bruton JD, Katz A, Westerblad H. The role of Ca2+ and calmodulin in insulin signalling in mammalian skeletal muscle. Acta Physiol Scand. 2001;171(3):259–265. doi:10.1046/j.1365-201x.2001.00828.x
   PubMedGoogle Scholar
• Lin WH, Chen MD, Liao WC, Lin PY. Relationship between brain serotonin and calmodulin in young, genetically obese (ob/ob) mice. J Formos Med Assoc. 1992;91(7):665–668.
   PubMedGoogle Scholar
• Parvathaneni S, Li Z, Sacks DB. Calmodulin influences MAPK signaling by binding KSR1. J Biol Chem. 2021;296:100577.
   PubMed Web of Science ®Google Scholar
• Iqbal Z, Fachim HA, Gibson JM, et al. Changes in the proteome profile of people achieving remission of type 2 diabetes after bariatric surgery. J Clin Med. 2021;10(16):3659.
   PubMed Web of Science ®Google Scholar
• van Bilsen JHM, van den Brink W, van den Hoek AM, et al. Mechanism-based biomarker prediction for low-grade inflammation in liver and adipose tissue. Front Physiol. 2021;12:703370.
   PubMed Web of Science ®Google Scholar
• Fadini GP, Albiero M, Bonora BM, Avogaro A. Angiogenic abnormalities in diabetes mellitus: mechanistic and clinical aspects. J Clin Endocrinol Metab. 2019;104(11):5431–5444.
   PubMed Web of Science ®Google Scholar
• Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121(6):2094–2101.
   PubMed Web of Science ®Google Scholar
• Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab. 2007;293(4):E1118–E1128.
   PubMed Web of Science ®Google Scholar
• Hammarstedt A, Gogg S, Hedjazifar S, Nerstedt A, Smith U. Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity. Physiol Rev. 2018;98(4):1911–1941.
   PubMed Web of Science ®Google Scholar